Sichuan Xieli Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INGENOL MEBUTATE, with a corresponding US DMF Number 29556.
Remarkably, this DMF maintains an Active status since its submission on July 17, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 23, 2015, and payment made on August 12, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II